Kindred Biosciences Inc (KIN)

7.05
0.05 0.71
NASDAQ : Health Care
Prev Close 7.00
Open 6.95
Day Low/High 6.95 / 7.10
52 Wk Low/High 2.90 / 6.84
Volume 57.87K
Avg Volume 140.80K
Exchange NASDAQ
Shares Outstanding 22.07M
Market Cap 156.70M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Kindred Biosciences To Announce Fourth Quarter And Year-End 2016 Financial Results

Kindred Biosciences To Announce Fourth Quarter And Year-End 2016 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Wednesday, March 1, 2017

These Insiders Are Still Finding Some Good Value in the Stock Market

These Insiders Are Still Finding Some Good Value in the Stock Market

Look at what they are buying.

The Final Fine-Tuned Gad Value Investment Portfolio for 2017

The Final Fine-Tuned Gad Value Investment Portfolio for 2017

We've made a few tweaks due to price changes, while others were based on a last-minute assessment of better value.

The 2017 Gad Value Investment Fund, Part 2

The 2017 Gad Value Investment Fund, Part 2

The second half of our value-stocks portfolio for the New Year.

Kindred Biosciences To Announce Third Quarter 2016 Financial Results

Kindred Biosciences To Announce Third Quarter 2016 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Monday, November 7, 2016

2 Bargains That Are Hiding in Plain Sight

2 Bargains That Are Hiding in Plain Sight

Kindred Biosciences and GM may be 'too cheap not to own.'

Winning Value Portfolio Is Set to Beat the Market

Even if the markets were to take a dive, the strength of our holdings will prevail.

Good Stocks Can Come in Small Packages

These 3 names may not draw attention, but they can draw profits.

Kindred Biosciences To Announce Second Quarter 2016 Financial Results

Kindred Biosciences To Announce Second Quarter 2016 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Monday, August 8, 2016

Value Portfolio Performs Well Amid Brexit Turmoil

A group of seven to 15 securities, if carefully selected, can provide all the diversification an investor needs.

It's Patient Capital's Time to Prosper

Brexit has caused active investors to flee and created an opportunity for those who are patient.

Kindred Biosciences Announces Positive Results From Pivotal Study Of KIND-010 For The Management Of Weight Loss In Cats

Kindred Biosciences Announces Positive Results From Pivotal Study Of KIND-010 For The Management Of Weight Loss In Cats

Conference call and webcast scheduled for 4:30 p.m. ET / 1:30 p.m. PT today

Portfolio Patience Is a Virtue

The energy rally is a good example.

Kindred Biosciences To Announce First Quarter 2016 Financial Results

Kindred Biosciences To Announce First Quarter 2016 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, May 5, 2016

Two Little Gems Are Hidden Amid Small-Caps

Sometimes, the under-research companies offer the biggest opportunities.

Kindred Biosciences Elects Herbert D. Montgomery To Join Its Board Of Directors

Kindred Biosciences Elects Herbert D. Montgomery To Join Its Board Of Directors

Highly Experienced Finance Executive to Join KindredBio's Board